BBH vs. BIB
Compare and contrast key facts about VanEck Vectors Biotech ETF (BBH) and ProShares Ultra Nasdaq Biotechnology (BIB).
BBH and BIB are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BBH is a passively managed fund by VanEck that tracks the performance of the MVIS US Listed Biotech 25 Index. It was launched on Dec 20, 2011. BIB is a passively managed fund by ProShares that tracks the performance of the NASDAQ Biotechnology Index (200%). It was launched on Apr 7, 2010. Both BBH and BIB are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BBH or BIB.
Correlation
The correlation between BBH and BIB is 0.92, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Performance
BBH vs. BIB - Performance Comparison
Key characteristics
BBH:
0.00
BIB:
0.04
BBH:
0.12
BIB:
0.30
BBH:
1.01
BIB:
1.04
BBH:
0.00
BIB:
0.03
BBH:
0.01
BIB:
0.15
BBH:
5.03%
BIB:
9.93%
BBH:
16.56%
BIB:
35.51%
BBH:
-72.69%
BIB:
-67.24%
BBH:
-27.38%
BIB:
-53.50%
Returns By Period
In the year-to-date period, BBH achieves a -4.08% return, which is significantly higher than BIB's -9.22% return. Over the past 10 years, BBH has outperformed BIB with an annualized return of 3.89%, while BIB has yielded a comparatively lower -1.34% annualized return.
BBH
-4.08%
-1.13%
-5.76%
-1.55%
2.50%
3.89%
BIB
-9.22%
-5.34%
-12.71%
-1.44%
-3.87%
-1.34%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BBH vs. BIB - Expense Ratio Comparison
BBH has a 0.35% expense ratio, which is lower than BIB's 0.95% expense ratio.
Risk-Adjusted Performance
BBH vs. BIB - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BBH vs. BIB - Dividend Comparison
BBH has not paid dividends to shareholders, while BIB's dividend yield for the trailing twelve months is around 0.89%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBH VanEck Vectors Biotech ETF | 0.00% | 0.43% | 0.47% | 0.21% | 0.36% | 0.34% | 0.50% | 0.55% | 0.30% | 0.27% | 0.00% | 0.00% |
BIB ProShares Ultra Nasdaq Biotechnology | 0.89% | 0.07% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
BBH vs. BIB - Drawdown Comparison
The maximum BBH drawdown since its inception was -72.69%, which is greater than BIB's maximum drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for BBH and BIB. For additional features, visit the drawdowns tool.
Volatility
BBH vs. BIB - Volatility Comparison
The current volatility for VanEck Vectors Biotech ETF (BBH) is 5.16%, while ProShares Ultra Nasdaq Biotechnology (BIB) has a volatility of 11.90%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than BIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.